Latest Insider Transactions at Marrone Bio Innovations Inc (MBII)
This section provides a real-time view of insider transactions for Marrone Bio Innovations Inc (MBII). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MARRONE BIO INNOVATIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MARRONE BIO INNOVATIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 12
2022
|
Amit Vasavada SVP & CTO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
285,892
-100.0%
|
-
|
Jul 12
2022
|
Amit Vasavada SVP & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
129,184
+31.12%
|
-
|
Jul 12
2022
|
Timothy B Johnson VP (Field and Technical) |
SELL
Sale (or disposition) back to the issuer
|
Direct |
212,374
-100.0%
|
-
|
Jul 12
2022
|
Timothy B Johnson VP (Field and Technical) |
BUY
Grant, award, or other acquisition
|
Direct |
102,167
+32.48%
|
-
|
Jul 12
2022
|
Ospraie Ag Science LLC Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
70,836,258
-100.0%
|
-
|
Jul 12
2022
|
Keith Pitts SVP & Chief Sust. Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
221,437
-100.0%
|
-
|
Jul 12
2022
|
Keith Pitts SVP & Chief Sust. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
102,950
+31.74%
|
-
|
Jul 12
2022
|
Linda V Moore Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
450,839
-100.0%
|
-
|
Jul 12
2022
|
Linda V Moore Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
316,153
+41.22%
|
-
|
Jul 12
2022
|
Matti Tiainen SVP, International Sales |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,684
-100.0%
|
-
|
Jul 12
2022
|
Matti Tiainen SVP, International Sales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,850,521
-100.0%
|
-
|
Jul 12
2022
|
Robert A Woods Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
468,527
-100.0%
|
-
|
Jul 12
2022
|
Robert A Woods Director |
BUY
Grant, award, or other acquisition
|
Direct |
455,027
+49.27%
|
-
|
Jul 12
2022
|
Yogesh Mago Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
321,770
-100.0%
|
-
|
Jul 12
2022
|
Yogesh Mago Director |
BUY
Grant, award, or other acquisition
|
Direct |
321,770
+50.0%
|
-
|
Jul 12
2022
|
Zachary S. Wochok Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,000
-100.0%
|
-
|
Jul 12
2022
|
Zachary S. Wochok Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
429,881
-100.0%
|
-
|
Jul 12
2022
|
Zachary S. Wochok Director |
BUY
Grant, award, or other acquisition
|
Direct |
429,081
+49.95%
|
-
|
Jul 12
2022
|
Keith Mc Govern Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
273,643
-100.0%
|
-
|
Jul 12
2022
|
Keith Mc Govern Director |
BUY
Grant, award, or other acquisition
|
Direct |
273,643
+50.0%
|
-
|
Jul 12
2022
|
Lara L Lee Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
167,812
-100.0%
|
-
|
Jul 12
2022
|
Lara L Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
167,812
+50.0%
|
-
|
Jul 12
2022
|
Kevin Helash Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
241,568
-100.0%
|
-
|
Jul 12
2022
|
Pamela G Marrone Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
6,442
-100.0%
|
-
|
Jul 12
2022
|
Pamela G Marrone Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,394,141
-100.0%
|
-
|
Jul 12
2022
|
Pamela G Marrone Director |
BUY
Grant, award, or other acquisition
|
Direct |
195,007
+7.53%
|
-
|
Jul 06
2022
|
Pamela G Marrone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.9%
|
$0
$0.8 P/Share
|
Jun 09
2022
|
Pamela G Marrone Director |
SELL
Open market or private sale
|
Direct |
20,492
-0.93%
|
$20,492
$1.18 P/Share
|
May 24
2022
|
Pamela G Marrone Director |
SELL
Open market or private sale
|
Direct |
21,009
-0.95%
|
$21,009
$1.15 P/Share
|
Mar 24
2022
|
Pamela G Marrone Director |
SELL
Open market or private sale
|
Direct |
22,728
-1.01%
|
$22,728
$1.11 P/Share
|
Mar 24
2022
|
Pamela G Marrone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.88%
|
$0
$0.8 P/Share
|
Feb 07
2022
|
Suping (Sue) Cheung Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,064
+50.0%
|
$0
$0.63 P/Share
|
Feb 07
2022
|
Kevin Helash Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
178,831
+42.54%
|
$0
$0.63 P/Share
|
Feb 07
2022
|
Timothy B Johnson VP (Field and Technical) |
BUY
Grant, award, or other acquisition
|
Direct |
66,623
+38.78%
|
$0
$0.63 P/Share
|
Feb 07
2022
|
Linda V Moore Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
111,039
+45.19%
|
$0
$0.63 P/Share
|
Feb 07
2022
|
Keith Pitts SVP & Chief Sust. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
108,312
+48.93%
|
$0
$0.63 P/Share
|
Feb 07
2022
|
Amit Vasavada SVP & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
79,481
+40.08%
|
$0
$0.63 P/Share
|
Dec 15
2021
|
Ospraie Ag Science LLC Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,553,583
+4.78%
|
$0
$0.75 P/Share
|
Nov 11
2021
|
Ardsley Advisory Partners LP > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
618,014
+3.26%
|
$0
$0.75 P/Share
|
Sep 15
2021
|
Pamela G Marrone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+1.32%
|
$0
$0.8 P/Share
|
Aug 24
2021
|
Pamela G Marrone Director |
SELL
Open market or private sale
|
Direct |
24,510
-1.1%
|
$24,510
$1.02 P/Share
|
Aug 23
2021
|
Kevin Helash Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,000
+43.4%
|
$47,000
$1.07 P/Share
|
Aug 23
2021
|
Robert A Woods Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+42.55%
|
$10,000
$1.03 P/Share
|
Aug 20
2021
|
Zachary S. Wochok Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,000
+28.57%
|
$2,000
$1.04 P/Share
|
Aug 09
2021
|
Pamela G Marrone Director |
SELL
Open market or private sale
|
Direct |
17,858
-0.79%
|
$17,858
$1.45 P/Share
|
Jul 26
2021
|
Pamela G Marrone Director |
SELL
Open market or private sale
|
Direct |
17,858
-0.79%
|
$17,858
$1.4 P/Share
|
Jul 09
2021
|
Pamela G Marrone Director |
SELL
Open market or private sale
|
Direct |
17,007
-0.76%
|
$17,007
$1.49 P/Share
|
Jun 24
2021
|
Pamela G Marrone Director |
SELL
Open market or private sale
|
Direct |
13,662
-0.61%
|
$13,662
$1.79 P/Share
|
Jun 09
2021
|
Pamela G Marrone Director |
SELL
Open market or private sale
|
Direct |
15,061
-0.67%
|
$15,061
$1.69 P/Share
|
Jun 08
2021
|
Matti Tiainen SVP, International Sales |
BUY
Exercise of conversion of derivative security
|
Indirect |
202,615
+4.01%
|
-
|